Management Team

Karen Pignet-Aiach

Founder, Chair and CEO

Founder, Chair, and CEO of Lysogene, Ms. Karen Pignet-Aiach is also the mother of a child with MPS IIIA.

Stéphane Durant des Aulnois

Chief Financial Officer

Stéphane Durant des Aulnois joined Lysogene in October 2019 as Chief Financial Officer, also supervising the Alliance Management and Business Development departments.

Ralph Laufer

Chief Scientific Officer

Dr. Ralph Laufer is responsible for Lysogene’s scientific activities.

Marie Deneux

Chief regulatory officer

Dr. Marie Deneux is in charge of defining and executing the regulatory strategy for the development and registration…

Michaël Hocquemiller

Head of Non-Clinical Development

Dr. Michaël Hocquemiller is in charge of the non-clinical development of Lysogene’s gene therapy products including…

Marie Trad

Chief clinical officer

Dr. Marie Trad, M.D., Chief Medical Officer is responsible for Lysogene’s medical and clinical development activities…

Lysogene COVID-19 update

Get In Touch

Don’t hesitate to contact us if you need more help.